CTNM
Contineum Therapeutics, Inc.
-0.62 (-4.51%)13.14USD176K成交股數304M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 0.00 | 0.00-100% | – | – | 0.00 | 50.0M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 12.7M | 11.6M | 12.8M | 11.0M | 14.1M | 13.7M | 9.7M | 7.9M | 7.8M | 8.0M | 6.5M | 9.5M |
| 銷售管理費用 | 4.7M | 5.3M | 4.4M | 3.9M | 3.8M | 4.4M | 3.2M | 3.0M | 2.2M | 1.7M | 1.6M | 1.6M |
| 營業利益 | −17.4M-3% | −16.9M-7% | −17.1M+32% | −14.9M+36% | −17.9M+80% | −18.1M+87% | −13.0M+61% | −10.9M-128% | −9.9M | −9.7M | −8.1M | 38.9M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | 77.9% |
| 稅後淨利 | −15.2M-6% | −14.5M-10% | −15.2M+48% | −12.8M+42% | −16.0M+91% | −16.0M+106% | −10.3M+64% | −9.0M-122% | −8.4M | −7.8M | −6.3M | 41.6M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | 83.1% |
| 稀釋 EPS | -0.40-35% | -0.39-37% | – | – | -0.62 | -0.62 | -0.40-85% | -0.39-146% | – | – | -2.69 | 0.84 |
| 稀釋股數 | 37.5M | 37.3M | 27.7M | – | 25.9M | 25.9M | 25.7M | 23.4M | 2.4M | 3.4M | 2.3M | 3.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 14.7M | 20.2M | 75.6M | 42.6M | 20.8M | 22.5M | 40.9M | 77.2M | 16.3M | 15.5M | – | – |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 250M | 261M | 277M | 191M | 183M | 198M | 216M | 221M | 124M | 130M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 10.7M | 11.3M | 15.7M | 10.4M | 11.5M | 13.5M | 5.8M | 3.9M | 6.6M | 5.7M | – | – |
| 股東權益 | 240M | 250M | 261M | 180M | 171M | 185M | 210M | 218M | −75.6M | −67.9M | −61.1M | −55.4M |
| 負債比 | 4.3% | 4.3% | 5.7% | 5.4% | 6.3% | 6.8% | 2.7% | 1.7% | 5.3% | 4.4% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −16.3M+13% | – | – | – | −14.4M | – | – | −8.0M | – | – | – |
| 資本支出 | – | 312K | – | – | – | 47K | – | – | 147K | – | – | – |
| 自由現金流 | – | −16.6M+15% | – | – | – | −14.5M | – | – | −8.1M | – | – | – |
| 折舊攤銷 | – | 83K | – | – | – | 78K | – | – | 61K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −60.0M | –% | -2.17 | −55.5M |
| FY2024 | 0.00 | -100.0% | −42.3M | –% | -2.18 | −33.4M |
| FY2023 | 50.0M | – | 22.7M | 45.4% | 0.08 | 18.9M |